Cargando…
The Changing Landscape of Hypertension and the Evolving Role of Vasodilatory Beta-Blockers
Autores principales: | Bakris, George L., Cohen, Jerome D., Gonzalez, Edgar R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437915/ http://dx.doi.org/10.18553/jmcp.2007.13.s5.2 |
Ejemplares similares
-
Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19
por: Esteban-Lucia, L, et al.
Publicado: (2021) -
Teprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye Disease
por: Kossler, Andrea Lora, et al.
Publicado: (2022) -
Oncology Pharmacy Management and the Evolving Role of Managed Care: Recommendations for a Changing Environment with a Focus on Multiple Myeloma
por: Dunn, Jeffrey D., et al.
Publicado: (2012) -
Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017) -
Intramuscular Interferon Beta-1a and Evolving Treatment Options and Outcomes Measurement for MS: Considerations for Managed Care
por: Barnes, Christopher J., et al.
Publicado: (2013)